Mark Thomas

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (14)

Johan Heemskerk

Emeritus Prof. of Cell Biochemistry of Thrombosis and Haemostasis

University of Maastricht

NETHERLANDS

View details

Paul Harrison

University of Birmingham

UNITED KINGDOM

View details

Natalie J. Jooss

University of Oxford

UNITED KINGDOM

View details

Samantha Montague

University of Birmingham

UNITED KINGDOM

View details

Steve P. Watson

UNITED KINGDOM

View details

Joanne Clark

University of Birmingham

UNITED KINGDOM

View details

Alexandre Slater

Dr at University of Birmingham

University of Birmingham

UNITED KINGDOM

View details

Anna Rowe

University of Birmingham

UNITED KINGDOM

View details

James Scriven

Senior Clinical Lecturer

University of Birmingham

UNITED KINGDOM

View details

Barrie Kellam

Professor of Medicinal Chemistry

University of Nottingham

UNITED KINGDOM

View details

Joanna Porter

University College London

UNITED KINGDOM

View details

Jonas Emsley

professor of macromolecular crystallography

University of Nottingham

UNITED KINGDOM

View details

Eleyna Martin

University of Birmingham

UNITED KINGDOM

View details

Natalie Poulter

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Thomas

Research Interests

Explore related searches

Contact this professor

Articles (10)

Characterizing the binding of glycoprotein VI with nanobody 35 reveals a novel monomeric structure of glycoprotein VI where the conformation of D1+D2 is independent of dimerization

Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation.

Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear

The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death

Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer

A Proteomics-Based Assessment of Inflammation Signatures in Endotoxemia

Platelet count and disease - editorial policy.

A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors.

Collaborators (14)

Johan Heemskerk

Paul Harrison

Natalie J. Jooss

Samantha Montague

Steve P. Watson

Joanne Clark

Alexandre Slater

Anna Rowe

James Scriven

Barrie Kellam

Joanna Porter

Jonas Emsley

Eleyna Martin

Natalie Poulter

Make your next move.